A Review of the Aging Process and Facilities Topic

Area of Science:

• Pharmaceutical Manufacturing
• Biopharmaceutical Industry
• Process Engineering

Background:

• Aging facilities and equipment are a growing concern in pharmaceutical and biopharmaceutical manufacturing.
• Obsolescence stems from underinvestment, inadequate maintenance, and resistance to modern technologies.
• Non-uniform scaling and insufficient process modifications for new products exacerbate these issues.

Purpose of the Study:

• To address the challenges and cases of aging processes and facilities.
• To examine the factors contributing to equipment and facility obsolescence.
• To discuss the implications of aging infrastructure in biopharmaceutical production.

Main Methods:

• Review of common issues in aging pharmaceutical manufacturing.
• Analysis of contributing factors to facility and process obsolescence.
• Case examples of aging processes and facilities.

Main Results:

• Identified underinvestment, poor maintenance, and neglected technology adoption as key drivers of aging infrastructure.
• Highlighted challenges in modifying existing processes for new products and non-uniform facility scaling.
• Noted significant regulatory hurdles for implementing new technologies, with approval times up to four years.

Conclusions:

• Aging facilities and processes present substantial risks to pharmaceutical and biopharmaceutical manufacturing.
• Proactive investment, diligent maintenance, and strategic technology adoption are crucial.
• Overcoming regulatory barriers is essential for modernizing manufacturing capabilities.